US court case to define EST patentability
Article Abstract:
The first case appealed to the US Court of Appeals for the Federal Circuit concerning the patentability of expressed sequence tags (ESTs) is to start on 3 May 2005, following a dispute between St. Louis, Missouri-based Monsanto and the US Patent and Trademark Office (USPTO). This case would clearly define, how much knowledge a patentee needs to have, of newly discovered ESTs works and whether the defined use meets the USPTO requirements.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
IP litigation in China could drive innovation
Article Abstract:
The increase in the number of litigation cases concerning intellectual property (IP) rights between major international pharmaceutical companies and their Chinese rivals may motivate China's biotech sector to concentrate on developing innovative products. Investments in domestic research and development (R&D) have increased in China as a consequence of the increase in IP protection.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
EPO neem patent revocation revives biopiracy debate
Article Abstract:
The patent based on the fungicidal properties of the neem tree was revocated on 8 March 2005 by the European Patent Office (EPO). This revocation by EPO was hailed as victory over biopiracy and gives a lesson to the biotech companies operating in developing countries that they cannot equate the traditional knowledge of indigenous communities with freely available public information.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Converting biotech scientists to managers. Giving patients a say: how to work with patient advocacy groups. Signal transduction inhibitors-a work in progress
- Abstracts: North America's fortunes hang on fate of dollar. Shrugging off turmoil, Mideast aims for growth. Companies find ways to make money go further
- Abstracts: Timeliness of financial reporting: applicability of disclosure theories in an emerging capital market. Motives for disclosure and non-disclosures: a framework and review of the evidence
- Abstracts: Executive turnover in UK firms: the impact of Cadbury. What has the invisible hand achieved? A unified approach to the measurement of international accounting harmony
- Abstracts: Constructing competitive advantage: the role of firm-constituent interactions. Believing one's own press: the causes and consequences of CEO celebrity